A research group at St. George Hospital (Australia) and others conducted a study to evaluate the effects of BioBran. They published a research paper titled “Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia):A Preliminary Clinical Study”.

This study was published in “Integrative Cancer Therapies January-March 2016: 1–7”.